Browsing by Author Yu Qiang

Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)
16-Nov-2010B55β-Associated PP2A Complex Controls PDK1-Directed Myc signaling and modulates rapamycin sensitivity in colorectal cancerTan, J.; Lee, P.L.; Li, Z.; Jiang, X.; Lim, Y.C.; Hooi, S.C.; Yu, Q. 
2-Sep-2011Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast CancersLee, S.T.; Li, Z.; Wu, Z.; Aau, M.; Guan, P.; Karuturi, R.K.M.; Liou, Y.C. ; Yu, Q. 
15-Sep-2011E2F1 suppresses Wnt/Β-catenin activity through transactivation of Β-catenin interacting protein ICATWu, Z.; Zheng, S.; Li, Z.; Tan, J.; Yu, Q. 
15-Apr-2011FOXQ1 regulates epithelial-mesenchymal transition in human cancersQiao, Y.; Jiang, X.; Lee, S.T.; Karuturi, R.K.M.; Hooi, S.C.; Yu, Q. 
15-Oct-2009miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25AXiaojing, Y.; Min, F.; Xia, J.; Zhenlong, W.; Zhimei, L.; Meiyee, A.; Qiang, Y. 
2013Molecular mechanisms of tumor resistance to PI3K-mTOR-targeted therapyTan, J.; Yu, Q. 
12-May-2011Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformationFeng, M.; Li, Z.; Aau, M.; Wong, C.H.; Yang, X.; Yu, Q. 
Oct-2013PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapyTan, J.; Li, Z.; Lee, P.L.; Guan, P.; Aau, M.Y.; Lee, S.T.; Feng, M.; Lim, C.Z.; Lee, E.Y.J.; Wee, Z.N.; Lim, Y.C.; Karuturi, R.K.M.; Yu, Q. 
Nov-2011Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damageWu, Z.; Lee, S.T.; Qiao, Y.; Li, Z.; Lee, P.L.; Lee, Y.J.; Jiang, X.; Tan, J.; Aau, M.; Lim, C.Z.H.; Yu, Q. 
2-Jul-2013Protein tyrosine phosphatase UBASH3B is overexpressed in triple-negative breast cancer and promotes invasion and metastasisLee, S.T.; Feng, M.; Wei, Y.; Li, Z.; Qiao, Y.; Guan, P.; Jiang, X.; Wong, C.H.; Huynh, K.; Wang, J.; Li, J.; Karuturi, K.M.; Tan, E.Y.; Hoon, D.S.B.; Kang, Y.; Yu, Q. 
1-Aug-2012TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep)Cheng, L.L.; Itahana, Y.; Lei, Z.D.; Chia, N.-Y.; Wu, Y.; Yu, Y.; Zhang, S.L.; Thike, A.A.; Pandey, A.; Rozen, S. ; Voorhoeve, P.M. ; Yu, Q. ; Tan, P.H.; Bay, B.H.; Itahana, K.; Tan, P.